Antivascular endothelial growth factor for macular oedema secondary to retinal vein occlusion: a systematic review and meta-analysis

PURPOSE: To evaluate the efficacy and safety of antivascular endothelial growth factor (anti-VEGF) agents in treating macular oedema due to retinal vein occlusion (RVO-ME). METHODS: Studies of randomised controlled trials were searched in PubMed, EMBASE, Cochrane databases and ClinicalTrials.gov reg...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Shanshan, Song, Zhihui, Li, Guangyao, Zhang, Chao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639114/
http://dx.doi.org/10.1136/bmjophth-2022-001086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9639114/
http://dx.doi.org/10.1136/bmjophth-2022-001086

Ejemplares similares